Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
An Sist Sanit Navar ; 45(2)2022 Jun 29.
Artigo em Espanhol | MEDLINE | ID: mdl-35781290

RESUMO

Inhaled anaesthetic induction with sevoflurane is very common in the pediatric population. Sevoflurane systemic effects are widely known, while not all the side effects are known. We present a four year-old child who developed a persistent supraventricular tachycardia after inhaled anaesthetic induction with sevoflurane. The arrhythmia did not end until sevoflurane was stopped and changed to an intravenous continuous perfusion of hypnotic drugs (propofol and remiphentanyl). The exact mechanism for such a causal relationship with sevoflurane administration is unknown, and possible diagnoses include atrioventricular nodal reentry tachycardia (AVNRT) and the existence of an accessory pathway. An episode of persistent supraventricular tachycardia with a clear causal relationship with sevoflurane administration is not found in the literature.


Assuntos
Anestésicos , Taquicardia por Reentrada no Nó Atrioventricular , Taquicardia Supraventricular , Criança , Pré-Escolar , Humanos , Sevoflurano/efeitos adversos , Taquicardia Supraventricular/induzido quimicamente
2.
Eur Neurol ; 61(1): 23-6, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-18948696

RESUMO

The initiation of a prophylactic treatment in a migraine sufferer depends upon the stratification of the patient's frequency of attacks and the disability they cause, as well as the patient's acute consumption and comorbid diseases. We report on 14 patients who were among a group of 618 migraine sufferers who received a new preventative treatment. These 14 patients developed an increase in the frequency of their migraine attacks that was possibly induced by this new prophylactic treatment. The clinical description of the migraine attacks remained the same but the frequency of the attacks of migraine without aura was dramatically increased. This is, to our knowledge, the first description of a possible precipitation of attacks of migraine without aura with a prophylactic treatment. There is no link with a specific class of prophylactic treatment. We hypothesize that the migraine sufferers who experienced aggravation after the new prophylactic drug had been introduced had a paradoxical decrease in the induction threshold for cortical spreading depression (CSD). Mechanisms of such a decrease are unknown and are probably multifactorial, but changes in serotonin neurotransmission have been experimentally demonstrated to modify cortical excitability and favour CSD. The aggravation was described only for attacks without aura. However, with only 14 patients, it is not possible to predict whether suffering from that the type of migraine is a factor that predisposes a patient to aggravation. While additional cases are necessary, physicians should be aware of the possibility that prophylactic treatment may exacerbate migraine attacks.


Assuntos
Transtornos de Enxaqueca/induzido quimicamente , Transtornos de Enxaqueca/prevenção & controle , Antagonistas Adrenérgicos beta/efeitos adversos , Adulto , Idoso , Anticonvulsivantes/efeitos adversos , Antidepressivos/efeitos adversos , Bloqueadores dos Canais de Cálcio/efeitos adversos , Ergotamina/efeitos adversos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Antagonistas da Serotonina/efeitos adversos
3.
Cir Pediatr ; 5(1): 37-41, 1992 Jan.
Artigo em Espanhol | MEDLINE | ID: mdl-1567747

RESUMO

Antisperm antibodies were studied in 44 patients with less than 14 years of age, with unilateral testicle torsion and other testicular pathologies with vascular and inflammatory processes. The clinical and evolution of testicular size after one year of initial evaluation were obtained. Four cases had positive antisperm antibodies: One testicular torsion, two acute orchitis and one varicocele. In all the cases including those with positive antibodies the testicular size was normal in both sides. These findings agree with the theory of initiation of autoimmune process after a unilateral testicular damage, although we can not give data to support any damage to the contralateral testes.


Assuntos
Autoanticorpos/análise , Espermatozoides/imunologia , Doenças Testiculares/imunologia , Fatores Etários , Criança , Humanos , Masculino , Orquite/etiologia , Orquite/imunologia , Puberdade , Torção do Cordão Espermático/etiologia , Torção do Cordão Espermático/imunologia , Doenças Testiculares/etiologia , Varicocele/etiologia , Varicocele/imunologia
4.
Oncogene ; 31(50): 5180-92, 2012 Dec 13.
Artigo em Inglês | MEDLINE | ID: mdl-22349815

RESUMO

Human epidermis is continuously exposed to environmental mutagenic hazard and is the most frequent target of human cancer. How the epidermis coordinates proliferation with differentiation to maintain homeostasis, even in hyperproliferative conditions, is unclear. For instance, overactivation of the proto-oncogene MYC in keratinocytes stimulates differentiation. Here we explore the cell cycle regulation as proliferating human keratinocytes commit to terminal differentiation upon loss of anchorage or overactivation of MYC. The S-phase of the cell cycle is deregulated as mitotic regulators are inhibited in the onset of differentiation. Experimental inhibition of mitotic kinase cdk1 or kinases of the mitosis spindle checkpoint Aurora B or Polo-like Kinase, triggered keratinocyte terminal differentiation. Furthermore, hyperactivation of the cell cycle by overexpressing the DNA replication regulator Cyclin E induced mitosis failure and differentiation. Inhibition of Cyclin E by shRNAs attenuated the induction of differentiation by MYC. In addition, we present evidence that Cyclin E induces DNA damage and the p53 pathway. The results provide novel clues for the mechanisms committing proliferative keratinocytes to differentiate, with implications for tissue homeostasis maintenance, HPV amplification and tumorigenesis.


Assuntos
Diferenciação Celular/fisiologia , Ciclina E/metabolismo , Queratinócitos/citologia , Queratinócitos/metabolismo , Aurora Quinase B , Aurora Quinases , Proteína Quinase CDC2/genética , Proteína Quinase CDC2/metabolismo , Proteínas de Ciclo Celular/genética , Proteínas de Ciclo Celular/metabolismo , Diferenciação Celular/genética , Proliferação de Células , Células Cultivadas , Ciclina E/genética , Dano ao DNA , Replicação do DNA , Células Epidérmicas , Epiderme/metabolismo , Epiderme/patologia , Humanos , Queratinócitos/patologia , Mitose/genética , Proteínas Serina-Treonina Quinases/genética , Proteínas Serina-Treonina Quinases/metabolismo , Proto-Oncogene Mas , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-myc/genética , Proteínas Proto-Oncogênicas c-myc/metabolismo , Fase S/genética , Proteína Supressora de Tumor p53/genética , Quinase 1 Polo-Like
5.
Cephalalgia ; 25(3): 184-90, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15689193

RESUMO

The objective of the present study was to investigate the influence of headache-related disability on the recognition and management of migraine by French general practitioners (GPs). Forty-nine teaching GPs at the Faculty of Medicine in the Nice-Sophia-Antipolis University were involved in this study. On one day, each patient who presented during the surgery hours of these GPs was invited to complete a questionnaire aimed at identifying if he/she was a headache sufferer and, if so, whether the headache corresponded to migraine and had an impact on his/her functional ability. Functional disability was measured by the short-form of the Headache Impact Test (HIT-6). Being blind to the patients' responses, the GPs completed a questionnaire for each patient aimed at identifying if he/she considered the patient to suffer from migraine and, if so, whether he/she managed the patient for migraine. A total of 696 patients were included in this study and 289 (41.52%) of them had episodic headache. According to the new International Headache Society (IHS) criteria, 113 (16.24%) patients suffered from headache without migrainous features and 176 (25.29%) patients were migraine sufferers (migraine according to IHS categories 1.1 and 1.2.1: 11.21%, and probable migraine according to IHS categories 1.6.1 and 1.6.2: 14.08%). The mean HIT score of these migraine sufferers was 59.1+/-8.8 and 50% of them presented with a very severe impact score (HIT score>60). Among the 176 migraine sufferers, 105 (59.7%) were not recognized as having migraine, 21 (11.9%) were recognized as having migraine but without migraine management and 50 (28.4%) were recognized as having migraine with migraine management. Recognition of migraine by GPs was statistically associated with the HIT score (OR=1.105, 95% CI: 1.056-1.157, P<0.001) and with the 1.1 and 1.2.1 IHS diagnostic categories (OR=2.942, 95% CI: 1.286-5.025, P=0.0107) whereas management of patients recognized as having migraine was only associated with the patient's age (OR=1.051, 95% CI: 1.000-1.104, P=0.0486). These results indicate that the continuing medical education of GPs should focus on the diagnosis of migraine and its impact on the lifestyle of the patient.


Assuntos
Avaliação da Deficiência , Transtornos de Enxaqueca/diagnóstico , Transtornos de Enxaqueca/epidemiologia , Medição da Dor/métodos , Atenção Primária à Saúde/estatística & dados numéricos , Medição de Risco/métodos , Perfil de Impacto da Doença , Atividades Cotidianas , Adulto , Feminino , França/epidemiologia , Pesquisas sobre Atenção à Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos de Enxaqueca/terapia , Padrões de Prática Médica/estatística & dados numéricos , Prevalência , Qualidade de Vida , Fatores de Risco , Distribuição por Sexo , Método Simples-Cego
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA